[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349998-105":59,"doc-detail-349998-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-csf-profiling-identifies-disease-specific-immune-responses-in-leptomeningeal-disease","Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease","","Integrative CSF profiling across leptomeningeal disease (LMD) reveals immune-active cerebrospinal fluid landscapes that differ by underlying tumor entity. Single-cell RNA and T cell receptor sequencing from CSF of CNS lymphoma, brain metastases, and glioblastoma are combined with deep TCR sequencing of blood and spatial transcriptomics of brain lesions. Results show clonal T cell expansion in CNSL-LMD, while BrMs and GB feature myeloid-dominant CSF profiles. Longitudinal CSF sampling tracks treatment response, tumor progression, and emerging resistant clones, supporting CSF liquid biopsy for immune monitoring and therapeutic stratification.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-csf-profiling-identifies-disease-specific-immune-responses-in-leptomeningeal-disease/349998/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-csf-profiling-identifies-disease-specific-immune-responses-in-leptomeningeal-disease/349998.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What approach is used to profile immune responses in leptomeningeal disease?","Question",{"text":112,"@type":113},"The study integrates single-cell RNA and TCR sequencing of CSF with deep TCR sequencing of blood and spatial transcriptomics of brain lesions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do immune profiles differ between CNSL-associated LMD and LMD from brain metastases or glioblastoma?",{"text":117,"@type":113},"CNSL-associated LMD shows pronounced T cell activation and clonal T cell expansion in CSF, while LMD from brain metastases and glioblastoma exhibits myeloid-dominant CSF profiles.",{"name":119,"@type":110,"acceptedAnswer":120},"What can longitudinal CSF analysis reveal during treatment?",{"text":121,"@type":113},"Longitudinal CSF profiling tracks treatment response and tumor progression, including dynamic immune changes and the emergence of resistant clones.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349998,1790180290,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nIntegrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease  \nAuthors  \nPaula Nieto, Svenja Klinsing, Ginevra Carat, ..., Holger Heyn, Pia S. Zeiner, Juan C. Nieto  \nCorrespondence  \n[juan.nieto@cnag.eu](juan.nieto@cnag.eu) (J.C.N.), [holger.heyn@cnag.eu](holger.heyn@cnag.eu) (H.H.), [zeiner@med.uni-frankfurt.de](zeiner@med.uni-frankfurt.de) (P.S.Z.)  \nIn brief  \nNieto et al. profile cerebrospinal fluid cells in leptomeningeal disease across tumor entities and compare them with blood and tissue lesions using single-cell and spatial approaches, showing that the CSFis an immune-active compartment reflecting immune responses holding the potential to capture treatment resistance and tumor progression.  \n• CNSL-LMD shows pronounced T cell activation and clonal T cell expansion in the CSF  \n• LMD from BrMs and GB exhibits myeloid-dominant CSF profiles  \n• Longitudinal CSF analysis tracks treatment response and tumor progression  \nNieto et al., 2026, Cell Reports Medicine 7, 102651  \nMarch 17, 2026 © 2026 The Authors. Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2026.102651](https://doi.org/10.1016/j.xcrm.2026.102651)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nIntegrative CSF profiling identifies disease-specific immune responsesin leptomeningeal disease  \nPaula Nieto,1,2 Svenja Klinsing,3,4,5 Ginevra Carat,1 Mareike Dettki,3 Domenica Marchese,1 Katharina J. Weber,5,6,7,8  \nSamuel Morabito,1 Patricia Lorden,1 Irene Ruano,1 Katharina Imkeller,5,6,7,8 M. Angels Velasco,9 Silvia Vidal,9 Juan L. Melero,10 Philipp Euskirchen,11,12 Marcus Czabanka,5,7,8,13 Karl H. Plate,5,6,7,8 Patrick N. Harter,14 Anna Pascual-Reguant,1 Joachim P. Steinbach,3,5,7,8 Holger Heyn,1,15,16,17,* Pia S. Zeiner,3,4,5,7,8,17,* and Juan C. Nieto1,17,18,*  \n1Centro Nacional de An´alisis Gen´omico (CNAG), Barcelona, Spain  \n2Universitat Pompeu Fabra (UPF), Barcelona, Spain  \n3Goethe University Frankfurt, University Hospital, Dr. Senckenberg Institute of Neurooncology, Frankfurt, Germany  \n4Goethe University Frankfurt, University Hospital, Department of Neurology, Frankfurt, Germany  \n5Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt, Germany  \n6Goethe University Frankfurt, University Hospital, Institute of Neurology (Edinger-Institute), Frankfurt, Germany  \n7Goethe University Frankfurt, Frankfurt Cancer Institute (FCI), Frankfurt, Germany  \n8German Cancer Research Center (DKFZ) Heidelberg, Germany and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany  \n9Biomedical Research Institut Sant Pau (IIB Sant Pau), Barcelona, Spain  \n10Omniscope Inc. , Barcelona, Spain  \n11Charite´ -Universita¨tsmedizin Berlin, corporate member of Freie Universita¨t Berlin und Humboldt Universita¨t zu Berlin, Department of Neuropathology, Berlin, Germany  \n12German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charit´e-Universit¨atsmedizin Berlin, Berlin, Germany  \n13Goethe University Frankfurt, University Hospital, Department of Neurosurgery, Frankfurt, Germany  \n14Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universit¨at Mu¨nchen, Munich, Germany  \n15University of Barcelona (UB), Barcelona, Spain  \n16ICREA, Barcelona, Spain  \n17Senior author  \n18Lead contact  \n*Correspondence: [juan.nieto@cnag.eu](juan.nieto@cnag.eu) (J.C. N.), [holger.heyn@cnag.eu](holger.heyn@cnag.eu) (H. H.), [zeiner@med.uni-frankfurt.de](zeiner@med.uni-frankfurt.de) (P.S.Z.) [https://doi.org/10.1016/j.xcrm.2026.102651](https://doi.org/10.1016/j.xcrm.2026.102651)  \nSUMMARY  \nLeptomeningeal disease (LMD) is a devastating manifestation of advanced cancer, marked by rapid neurological decline and limited treatment options. Immune profiling in central nervous system (CNS) neoplasms, including LMD, is critical for understanding disease biology and guiding therapy. Here, we use single-cell RNA and T cell receptor (TCR) sequencing of cerebrospinal ","cbCailc2APZDNTVT","https://ap.wps.com/l/cbCailc2APZDNTVT","pdf",9073046,22,"English","# Summary\n# Introduction\n# Results and key findings","[{\"question\":\"What approach is used to profile immune responses in leptomeningeal disease?\",\"answer\":\"The study integrates single-cell RNA and TCR sequencing of CSF with deep TCR sequencing of blood and spatial transcriptomics of brain lesions.\"},{\"question\":\"How do immune profiles differ between CNSL-associated LMD and LMD from brain metastases or glioblastoma?\",\"answer\":\"CNSL-associated LMD shows pronounced T cell activation and clonal T cell expansion in CSF, while LMD from brain metastases and glioblastoma exhibits myeloid-dominant CSF profiles.\"},{\"question\":\"What can longitudinal CSF analysis reveal during treatment?\",\"answer\":\"Longitudinal CSF profiling tracks treatment response and tumor progression, including dynamic immune changes and the emergence of resistant clones.\"}]","Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease | PDF",1790086664,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27d7fb43fb4d556a6a5607d61a3d7b2c.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d813dba1900ed06ffffdc25017ef43b7.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51a5a6c129f55702726ec0ecc98243a8.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec1cf77dbd3b391970e474fb71427e2d.webp",980,1272]